Digestive Disease Interventions 2022; 06(03): 185-196
DOI: 10.1055/s-0042-1749383
Review Article

A Review of Direct Endobiliary Techniques for the Management of Biliary Conditions

1   Division of Vascular and Interventional Radiology, Russell H Morgan Department of Radiology and Radiological Science, The Johns Hopkins Hospital, Baltimore, Maryland
,
1   Division of Vascular and Interventional Radiology, Russell H Morgan Department of Radiology and Radiological Science, The Johns Hopkins Hospital, Baltimore, Maryland
,
1   Division of Vascular and Interventional Radiology, Russell H Morgan Department of Radiology and Radiological Science, The Johns Hopkins Hospital, Baltimore, Maryland
› Institutsangaben
Funding None.

Abstract

A majority of patients with cholangiocarcinoma and malignant biliary obstruction cannot undergo surgery for treatment as they present late in the disease course. It is crucial to relieve biliary obstruction in these conditions, for which metallic stents are commonly used. However, these stents have a high rate of occlusion due to the ingrowth of malignant tissue. In this review, we will discuss the use of direct endobiliary therapies that can be used either independently or in combination with metallic stents.



Publikationsverlauf

Eingereicht: 07. Dezember 2021

Angenommen: 04. April 2022

Artikel online veröffentlicht:
13. Juni 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Coelho-Prabhu N, Baron TH. Endoscopic retrograde cholangiopancreatography in the diagnosis and management of cholangiocarcinoma. Clin Liver Dis 2010; 14 (02) 333-348
  • 2 Paranandi B, Oppong KW. Biliary strictures: endoscopic assessment and management. Frontline Gastroenterol 2017; 8 (02) 133-137
  • 3 Costamagna G, Shah SK, Tringali A. Current management of postoperative complications and benign biliary strictures. Gastrointest Endosc Clin N Am 2003; 13 (04) 635-648 , ix
  • 4 Strand DS, Cosgrove ND, Patrie JT. et al. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma. Gastrointest Endosc 2014; 80 (05) 794-804
  • 5 Figueroa-Barojas P, Bakhru MR, Habib NA. et al. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. J Oncol 2013; 2013: 910897
  • 6 Mohan BP, Chandan S, Khan SR. et al. Photodynamic therapy (PDT), radiofrequency ablation (RFA) with biliary stents in palliative treatment of unresectable extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Clin Gastroenterol 2022; 56 (02) e153-e160
  • 7 Kocak Z, Ozkan H, Adli M, Garipagaoglu M, Kurtman C, Cakmak A. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct. Radiat Med 2005; 23 (03) 200-207
  • 8 Kong YL, Zhang HY, Liu CL. et al. Improving biliary stent patency for malignant obstructive jaundice using endobiliary radiofrequency ablation: experience in 150 patients. Surg Endosc 2022; 36 (03) 1789-1798
  • 9 Kim HS, Lee DK, Kim HG. et al. Features of malignant biliary obstruction affecting the patency of metallic stents: a multicenter study. Gastrointest Endosc 2002; 55 (03) 359-365
  • 10 Inoue T, Kitano R, Yoneda M. Endobiliary radiofrequency ablation for ingrowth occlusion after bilateral metal stent placement in patients with malignant hilar biliary obstruction. Endosc Int Open 2021; 9 (06) E907-E908
  • 11 Dumoulin FL, Gerhardt T, Fuchs S. et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 2003; 57 (07) 860-867
  • 12 O'Neal D, Cohen T, Peterson C, Barr RG. Contrast-enhanced ultrasound-guided radiofrequency ablation of renal tumors. J Kidney Cancer VHL 2018; 5 (01) 7-14
  • 13 Pescatori LC, Torcia P, Nicosia L, Mauri G, Rossi UG, Cariati M. Which needle in the treatment of thyroid nodules?. Gland Surg 2018; 7 (02) 111-116
  • 14 Yin Z, Jin H, Ma T, Zhou Y, Yu M, Jian Z. A meta-analysis of long-term survival outcomes between surgical resection and radiofrequency ablation in patients with single hepatocellular carcinoma ≤ 2 cm (BCLC very early stage). Int J Surg 2018; 56: 61-67
  • 15 Schueller G, Kettenbach J, Sedivy R. et al. Heat shock protein expression induced by percutaneous radiofrequency ablation of hepatocellular carcinoma in vivo. Int J Oncol 2004; 24 (03) 609-613
  • 16 Haen SP, Pereira PL, Salih HR, Rammensee HG, Gouttefangeas C. More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol 2011; 2011: 160250
  • 17 Rai R, Richardson C, Flecknell P, Robertson H, Burt A, Manas DM. Study of apoptosis and heat shock protein (HSP) expression in hepatocytes following radiofrequency ablation (RFA). J Surg Res 2005; 129 (01) 147-151
  • 18 Ali MY, Grimm CF, Ritter M. et al. Activation of dendritic cells by local ablation of hepatocellular carcinoma. J Hepatol 2005; 43 (05) 817-822
  • 19 Liang HH, Peng ZW, Chen MS. et al. Efficacy of combining temperature- and power-controlled radiofrequency ablation for malignant liver tumors. Chin J Cancer 2010; 29 (04) 408-412
  • 20 Petersen HH, Chen X, Pietersen A, Svendsen JH, Haunso S. Temperature-controlled radiofrequency ablation of cardiac tissue: an in vitro study of the impact of electrode orientation, electrode tissue contact pressure and external convective cooling. J Interv Card Electrophysiol 1999; 3 (03) 257-262
  • 21 Cho JH, Lee KH, Kim JM, Kim YS, Lee DH, Jeong S. Safety and effectiveness of endobiliary radiofrequency ablation according to the different power and target temperature in a swine model. J Gastroenterol Hepatol 2017; 32 (02) 521-526
  • 22 Cho JH, Jeong S, Kim EJ, Kim JM, Kim YS, Lee DH. Long-term results of temperature-controlled endobiliary radiofrequency ablation in a normal swine model. Gastrointest Endosc 2018; 87 (04) 1147-1150
  • 23 Camus M, Napoléon B, Vienne A. et al. Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy: a multicenter prospective study. Gastrointest Endosc 2018; 88 (03) 511-518
  • 24 Han K, Ko HK, Kim KW, Won HJ, Shin YM, Kim PN. Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis. J Vasc Interv Radiol 2015; 26 (07) 943-948
  • 25 Yang J, Wang J, Zhou H. et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial. Endoscopy 2018; 50 (08) 751-760
  • 26 Sofi AA, Khan MA, Das A. et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc 2018; 87 (04) 944-951.e1
  • 27 Zorrón Pu L, de Moura EGH, Bernardo WM. et al. Endoscopic stenting for inoperable malignant biliary obstruction: a systematic review and meta-analysis. World J Gastroenterol 2015; 21 (47) 13374-13385
  • 28 Loew BJ, Howell DA, Sanders MK. et al. Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc 2009; 70 (03) 445-453
  • 29 Parsi MA. Common controversies in management of biliary strictures. World J Gastroenterol 2017; 23 (07) 1119-1124
  • 30 Costamagna G, Pandolfi M, Mutignani M, Spada C, Perri V. Long-term results of endoscopic management of postoperative bile duct strictures with increasing numbers of stents. Gastrointest Endosc 2001; 54 (02) 162-168
  • 31 Costamagna G, Tringali A, Mutignani M. et al. Endotherapy of postoperative biliary strictures with multiple stents: results after more than 10 years of follow-up. Gastrointest Endosc 2010; 72 (03) 551-557
  • 32 Khan MA, Baron TH, Kamal F. et al. Efficacy of self-expandable metal stents in management of benign biliary strictures and comparison with multiple plastic stents: a meta-analysis. Endoscopy 2017; 49 (07) 682-694
  • 33 Costamagna G, Familiari P, Tringali A, Mutignani M. Multidisciplinary approach to benign biliary strictures. Curr Treat Options Gastroenterol 2007; 10 (02) 90-101
  • 34 Hu B, Gao DJ, Wu J, Wang TT, Yang XM, Ye X. Intraductal radiofrequency ablation for refractory benign biliary stricture: pilot feasibility study. Dig Endosc 2014; 26 (04) 581-585
  • 35 Kadayifci A, Atar M, Forcione DG, Casey BW, Kelsey PB, Brugge WR. Radiofrequency ablation for the management of occluded biliary metal stents. Endoscopy 2016; 48 (12) 1096-1101
  • 36 Nayar MK, Oppong KW, Bekkali NLH, Leeds JS. Novel temperature-controlled RFA probe for treatment of blocked metal biliary stents in patients with pancreaticobiliary cancers: initial experience. Endosc Int Open 2018; 6 (05) E513-E517
  • 37 Mehendiratta V, Desilets DJ. Use of radiofrequency ablation probe for eradication of residual adenoma after ampullectomy. Gastrointest Endosc 2015; 81 (04) 1055-1056
  • 38 Valente R, Urban O, Del Chiaro M. et al. ERCP-directed radiofrequency ablation of ampullary adenomas: a knife-sparing alternative in patients unfit for surgery. Endoscopy 2015; 47 (01) , Suppl 1 UCTN E515-E516
  • 39 Tian Q, Wang G, Zhang Y. et al. Endoscopic radiofrequency ablation combined with fully covered self-expandable metal stent for inoperable periampullary carcinoma in a liver transplant patient: a case report. Medicine (Baltimore) 2017; 96 (05) e5790
  • 40 Rustagi T, Irani S, Reddy DN. et al. Radiofrequency ablation for intraductal extension of ampullary neoplasms. Gastrointest Endosc 2017; 86 (01) 170-176
  • 41 Raees A, Kamran M, Özkan H, Jafri W. Updates on the diagnosis and management of hepatocellular carcinoma. Euroasian J Hepatogastroenterol 2021; 11 (01) 32-40
  • 42 Dou JP, Liang P, Yu J. Microwave ablation for liver tumors. Abdom Radiol (NY) 2016; 41 (04) 650-658
  • 43 Hoffmann R, Rempp H, Erhard L. et al. Comparison of four microwave ablation devices: an experimental study in ex vivo bovine liver. Radiology 2013; 268 (01) 89-97
  • 44 Uyanık SA, Öğüşlü U, Yılmaz B, Çevik H, Atlı E, Gümüş B. Percutaneous intraductal microwave ablation of malignant biliary strictures: initial experience. AJR Am J Roentgenol 2020; 215 (03) 753-759
  • 45 Zhou YF. High intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol 2011; 2 (01) 8-27
  • 46 Wu F. High intensity focused ultrasound: a noninvasive therapy for locally advanced pancreatic cancer. World J Gastroenterol 2014; 20 (44) 16480-16488
  • 47 Li PZ, Zhu SH, He W. et al. High-intensity focused ultrasound treatment for patients with unresectable pancreatic cancer. Hepatobiliary Pancreat Dis Int 2012; 11 (06) 655-660
  • 48 Cai PF, Gu H, Zhu LJ, Xu YS, Deng HY. Stent insertion with high-intensity focused ultrasound ablation for malignant biliary obstruction: a protocol of systematic review and meta-analysis. Medicine (Baltimore) 2021; 100 (03) e23922
  • 49 Ikeda H, Kuroda C, Uchida H. et al. [Intraluminal irradiation with iridium-192 wires for extrahepatic bile duct carcinoma–a preliminary report (author's transl)]. Nippon Igaku Hoshasen Gakkai Zasshi 1979; 39 (12) 1356-1358
  • 50 Itami J, Saegusa K, Tsuchiya Y. et al. [Intracavitary high dose rate afterloading irradiation of inoperable malignant bile duct obstruction]. Strahlenther Onkol 1986; 162 (02) 105-110
  • 51 Köster R, Schmidt H, Greuel H. [Afterloading method for the irradiation of malignant bile duct obstructions]. Strahlentherapie 1982; 158 (11) 678-680
  • 52 Montemaggi P, Costamagna G, Dobelbower RR. et al. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma. Int J Radiat Oncol Biol Phys 1995; 32 (02) 437-443
  • 53 Kamada T, Saitou H, Takamura A, Nojima T, Okushiba SI. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys 1996; 34 (04) 767-774
  • 54 González González D, Gouma DJ, Rauws EA, van Gulik TM, Bosma A, Koedooder C. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Ann Oncol 1999; 10 (Suppl. 04) 215-220
  • 55 Zhu HD, Guo JH, Zhu GY. et al. A novel biliary stent loaded with (125)I seeds in patients with malignant biliary obstruction: preliminary results versus a conventional biliary stent. J Hepatol 2012; 56 (05) 1104-1111
  • 56 Li Z, Jiao D, Han X, Liu Z. A comparative study of self-expandable metallic stent combined with double 125I seeds strands or single 125I seeds strand in the treatment of advanced perihilar cholangiocarcinoma with malignant obstructive jaundice. OncoTargets Ther 2021; 14: 4077-4086
  • 57 Fritz P, Brambs HJ, Schraube P, Freund U, Berns C, Wannenmacher M. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas. Int J Radiat Oncol Biol Phys 1994; 29 (04) 855-861
  • 58 Williams TM, Majithia L, Wang SJ, Thomas Jr CR. Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer. Semin Radiat Oncol 2014; 24 (02) 94-104
  • 59 Skowronek J, Sowier A, Skrzywanek P. Trans-hepatic technique and intraluminal pulsed dose rate (PDR-BT) brachytherapy in treatment of locally advanced bile duct and pancreas cancer. J Contemp Brachytherapy 2009; 1 (02) 97-104
  • 60 Xu X, Li J, Wu J, Zhu R, Ji W. A systematic review and meta-analysis of intraluminal brachytherapy versus stent alone in the treatment of malignant obstructive jaundice. Cardiovascular and Interventional Radiology 2018; 41 (02) 206-217
  • 61 Mattiucci GC, Autorino R, Tringali A. et al. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer. Brachytherapy 2015; 14 (03) 401-404
  • 62 Halperin EC, Wazer DE, Perez CA, Brady LW. eds. Perez and Brady's Principles and Practice of Radiation Oncology. 7th ed. Wolters Kluwer;; 2019
  • 63 Dolak W, Schreiber F, Schwaighofer H. et al; Austrian Biliary RFA Study Group. Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc 2014; 28 (03) 854-860
  • 64 Sharaiha RZ, Natov N, Glockenberg KS, Widmer J, Gaidhane M, Kahaleh M. Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit?. Dig Dis Sci 2014; 59 (12) 3099-3102
  • 65 Tal AO, Vermehren J, Friedrich-Rust M. et al. Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction. World J Gastrointest Endosc 2014; 6 (01) 13-19
  • 66 Sharaiha RZ, Sethi A, Weaver KR. et al. Impact of radiofrequency ablation on malignant biliary strictures: results of a collaborative registry. Dig Dis Sci 2015; 60 (07) 2164-2169
  • 67 Kallis Y, Phillips N, Steel A. et al. Analysis of endoscopic radiofrequency ablation of biliary malignant strictures in pancreatic cancer suggests potential survival benefit. Dig Dis Sci 2015; 60 (11) 3449-3455
  • 68 Laquière A, Boustière C, Leblanc S, Penaranda G, Désilets E, Prat F. Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma. Surg Endosc 2016; 30 (03) 1242-1248
  • 69 Wang F, Li Q, Zhang X. et al. Endoscopic radiofrequency ablation for malignant biliary strictures. Exp Ther Med 2016; 11 (06) 2484-2488
  • 70 Schmidt A, Bloechinger M, Weber A. et al. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma. United European Gastroenterol J 2016; 4 (04) 570-579
  • 71 Laleman W, van der Merwe S, Verbeke L. et al. A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study. Endoscopy 2017; 49 (10) 977-982
  • 72 Lee YN, Jeong S, Choi HJ. et al. The safety of newly developed automatic temperature-controlled endobiliary radiofrequency ablation system for malignant biliary strictures: a prospective multicenter study. J Gastroenterol Hepatol 2019; 34 (08) 1454-1459
  • 73 Kang H, Chung MJ, Cho IR. et al. Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL. Surg Endosc 2021; 35 (01) 63-73
  • 74 Uyanık SA, Öğüşlü U, Çevik H, Atlı E, Yılmaz B, Gümüş B. Percutaneous endobiliary ablation of malignant biliary strictures with a novel temperature-controlled radiofrequency ablation device. Diagn Interv Radiol 2021; 27 (01) 102-108
  • 75 Chi C, Long C, Li G, Ning C, Wu H. Biliary stent implantation combined with high intensity-focused ultrasound ablation for the treatment of malignant biliary obstruction. J Interv Radiol 2011; 20 (10) 792-795
  • 76 Long C, Chi C, Wu H. Biliary double stents implantation combined with high intensity-focused ultrasound ablation for the treatment of malignant obstructive jaundice. Pr J Cancer 2014; 19: 1705-1707
  • 77 Niu S, Cheng L, Qiao Y, Fu YF, Cao C. Combined stent insertion and high-intensity focused ultrasound ablation for patients with malignant obstructive jaundice. Surg Laparosc Endosc Percutan Tech 2016; 26 (06) 488-492
  • 78 Hui X, Zhou C, Gong Z. Stent insertion combined with high-intensity focused ultrasound ablation for malignant obstructive jaundice caused by pancreatic carcinoma. J Reg Anat Oper Surg 2020; 26 (09) 698-701
  • 79 Yang SY, Liu F, Liu Y, Xia FF, Fu YF. Stent insertion with high-intensity focused ultrasound ablation for distal biliary obstruction secondary to pancreatic carcinoma. Medicine (Baltimore) 2020; 99 (06) e19099
  • 80 Cao Q, Li JJ, Feng T, Shi YB, Wang G, Xia FF. Unilateral stent insertion with high-intensity focused ultrasound ablation for hilar cholangiocarcinoma. Surg Laparosc Endosc Percutan Tech 2020; 30 (03) 281-284
  • 81 Zhang FQ, Li L, Huang PC, Xia FF, Zhu L, Cao C. Stent insertion with high intensity-focused ultrasound ablation for biliary obstruction caused by pancreatic carcinoma: a randomized controlled trial. Surg Laparosc Endosc Percutan Tech 2021; 31 (03) 298-303
  • 82 Skowronek J, Zwierzchowski G. Brachytherapy in the treatment of bile duct cancer - a tough challenge. J Contemp Brachytherapy 2017; 9 (02) 187-195
  • 83 Yoshioka Y, Ogawa K, Oikawa H. et al; Japanese Radiation Oncology Study Group (JROSG). Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: a propensity-score matched-pair analysis. Int J Radiat Oncol Biol Phys 2014; 89 (04) 822-829
  • 84 Ghafoori AP, Nelson JW, Willett CG. et al. Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 2011; 81 (03) 654-659
  • 85 Shin HS, Seong J, Kim WC. et al. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys 2003; 57 (01) 105-112
  • 86 Schleicher UM, Staatz G, Alzen G, Andreopoulos D. Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors. Strahlenther Onkol 2002; 178 (12) 682-687
  • 87 Takamura A, Saito H, Kamada T. et al. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 2003; 57 (05) 1357-1365
  • 88 Wang Y, Man Z, Hu X. et al. Percutaneous biliary stent with intraluminal brachytherapy versus palliative surgery in the management of extrahepatic cholangiocarcinoma. Int J Clin Oncol 2021; 26 (05) 933-940
  • 89 Chi Z, Chen L, Huang J. et al. A novel combination of percutaneous stenting with iodine-125 seed implantation and chemotherapy for the treatment of pancreatic head cancer with obstructive jaundice. Brachytherapy 2021; 20 (01) 218-225
  • 90 Wang T, Liu S, Zheng YB. et al. Clinical study on using 125I seeds articles combined with biliary stent implantation in the treatment of malignant obstructive jaundice. Anticancer Res 2017; 37 (08) 4649-4653
  • 91 Jiao D, Wu G, Ren J, Han X. Study of self-expandable metallic stent placement intraluminal 125I seed strands brachytherapy of malignant biliary obstruction. Surg Endosc 2017; 31 (12) 4996-5005
  • 92 Chen Y, Wang XL, Yan ZP. et al. The use of 125I seed strands for intraluminal brachytherapy of malignant obstructive jaundice. Cancer Biother Radiopharm 2012; 27 (05) 317-323
  • 93 Singh V, Kapoor R, Solanki KK, Singh G, Verma GR, Sharma SC. Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: a pilot study. Liver Int 2007; 27 (03) 347-352
  • 94 Chen Y, Wang XL, Yan ZP. et al. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice. World J Gastroenterol 2004; 10 (23) 3506-3510
  • 95 Bruha R, Petrtyl J, Kubecova M. et al. Intraluminal brachytherapy and self-expandable stents in nonresectable biliary malignancies – the question of long-term palliation. Hepatogastroenterology 2001; 48 (39) 631-637